Cargando…

Expression of HLA-DR in Cytotoxic T Lymphocytes: A Validated Predictive Biomarker and a Potential Therapeutic Strategy in Breast Cancer

SIMPLE SUMMARY: More than 50% of breast cancer (BC) patients selected for neoadjuvant chemotherapy (NACT) are subjected to at least a 6-month regimen of this treatment without a clear benefit, probably delaying more effective therapeutic strategies and being exposed to potential treatment-associated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saraiva, Diana P., Azeredo-Lopes, Sofia, Antunes, Ana, Salvador, Rute, Borralho, Paula, Assis, Beatriz, Pereira, Isabel L., Seabra, Zita, Negreiros, Ida, Jacinto, António, Braga, Sofia, Cabral, M. Guadalupe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345089/ https://www.ncbi.nlm.nih.gov/pubmed/34359741 http://dx.doi.org/10.3390/cancers13153841

Ejemplares similares

HLA-DR in Cytotoxic T Lymphocytes Predicts Breast Cancer Patients' Response to Neoadjuvant Chemotherapy
por: Saraiva, Diana P., et al.
Publicado: (2018)

Circulating low density neutrophils of breast cancer patients are associated with their worse prognosis due to the impairment of T cell responses
por: Saraiva, Diana P., et al.
Publicado: (2021)

How many diseases is triple negative breast cancer: the protagonism of the immune microenvironment
por: Saraiva, Diana P, et al.
Publicado: (2017)

Establishment of a 3D Co-culture With MDA-MB-231 Breast Cancer Cell Line and Patient-Derived Immune Cells for Application in the Development of Immunotherapies
por: Saraiva, Diana P., et al.
Publicado: (2020)

Human Microbiota and Breast Cancer—Is There Any Relevant Link?—A Literature Review and New Horizons Toward Personalised Medicine
por: Alpuim Costa, Diogo, et al.
Publicado: (2021)

HLA-DM Interactions with Intermediates in HLA-DR Maturation and a Role for HLA-DM in Stabilizing Empty HLA-DR Molecules
por: Denzin, Lisa K., et al.
Publicado: (1996)

Association of HLA-DR1, HLA-DR13, and HLA-DR16 Polymorphisms with Systemic Lupus Erythematosus: A Meta-Analysis
por: Wang, Tingrui, et al.
Publicado: (2022)

Next-Generation Sequencing in Breast Cancer Management: A Case Report of Genomic Tumour Evolution over Time
por: Batista, Marta Vaz, et al.
Publicado: (2021)

Matching for HLA-DR excluding diabetogenic HLA-DR3 and HLA-DR4 predicts insulin independence after pancreatic islet transplantation
por: Ballou, Cassandra, et al.
Publicado: (2023)

Increased HLA-DR expression and cortical demyelination in MS links with HLA-DR15
por: Enz, Lukas Simon, et al.
Publicado: (2019)

Association of HLA-DR3 and HLA-DR15 Polymorphisms with Risk of Systemic Lupus Erythematosus
por: Xue, Ke, et al.
Publicado: (2018)

T cells sensitized to synthetic HLA-DR3 peptide give evidence of continuous presentation of denatured HLA-DR3 molecules by HLA-DP
Publicado: (1989)

T cell recognition of self-human histocompatibility leukocyte antigens (HLA)-DR peptides in context of syngeneic HLA-DR molecules
Publicado: (1992)

HLA class II regulation and structure. Analysis with HLA-DR3 and HLA-DP point mutants
Publicado: (1985)

Fibrillary Glomerulonephritis Is Associated With HLA-DR7 and HLA-B35 Antigens
por: Andeen, Nicole K., et al.
Publicado: (2020)

Klotho and lean mass as novel cardiovascular risk factors in hemodialysis patients
por: Martins, Ana Rita, et al.
Publicado: (2023)

Alloreactive cytolytic T cell clones with dual recognition of HLA-B27 and HLA-DR2 antigens. Selective involvement of CD8 in their class I-- directed cytotoxicity
Publicado: (1987)

Identification of a specific HLA DR2 Ia molecule as a restriction element for measles virus-specific HLA class II-restricted cytotoxic T cell clones
Publicado: (1985)

The HLA-DRα Chain Is Modified by Polyubiquitination
por: Lapaque, Nicolas, et al.
Publicado: (2009)

Effect of Selenium on HLA-DR Expression of Thyrocytes
por: Balázs, Csaba, et al.
Publicado: (2012)

HLA-DR Association in Papillary Thyroid Carcinoma
por: Amoli, Mahsa M., et al.
Publicado: (2010)

The curious case of HLA‐DR‐positive APL
por: Devi, Kanta, et al.
Publicado: (2020)

Reverse-SSO hybridization provides an accurate and simple HLA-DR typing--a comparative study with HLA-DR serologic typing.
por: Lee, K. W., et al.
Publicado: (1994)

Cross-reactivity of self-HLA-restricted Epstein-Barr virus-specific cytotoxic T lymphocytes for allo-HLA determinants
Publicado: (1983)

Lack of correlation between lymphocyte activating determinants and HLA-DR on acute leukaemias.
por: Taylor, G. M., et al.
Publicado: (1984)

Structural requirements for pairing of alpha and beta chains in HLA-DR and HLA-DP molecules
Publicado: (1990)

HLA-DM Captures Partially Empty HLA-DR Molecules for Catalyzed Peptide Removal
por: Anders, Anne-Kathrin, et al.
Publicado: (2010)

miR-143 or miR-145 overexpression increases cetuximab-mediated antibody-dependent cellular cytotoxicity in human colon cancer cells
por: Gomes, Sofia E., et al.
Publicado: (2016)

A myelin basic protein peptide is recognized by cytotoxic T cells in the context of four HLA-DR types associated with multiple sclerosis
Publicado: (1991)

Potential Role for HIV-Specific CD38(−)/HLA-DR(+) CD8(+) T Cells in Viral Suppression and Cytotoxicity in HIV Controllers
por: Hua, Stéphane, et al.
Publicado: (2014)

HLA restriction of human cytotoxic T lymphocytes specific for influenza virus. Poor recognition of virus associated with HLA A2
Publicado: (1978)

Cytotoxic T lymphocytes from HLA-A2 transgenic mice specific for HLA-A2 expressed on human cells
Publicado: (1988)

Molecular Analysis of Thymopentin Binding to HLA-DR Molecules
por: Liu, Zuojia, et al.
Publicado: (2007)

HLA-DR polymorphism affects the interaction with CD4
Publicado: (1995)

Expression of HLA-DR antigen in large bowel carcinoma.
por: Chang, E. S., et al.
Publicado: (1995)

HLA-DR expression, cytokines and bioactive lipids in sepsis
por: Das, Undurti
Publicado: (2014)

HLA-DR expression on monocytes is decreased in polytraumatized patients
por: Vester, Helen, et al.
Publicado: (2015)

The HLA-DR4 family of haplotypes consists of series of distinct DR and DS molecules
Publicado: (1984)

Letter Regarding “Fibrillary Glomerulonephritis Is Associated With HLA-DR7 and HLA-B35 Antigens”
por: El Ters, Mireille, et al.
Publicado: (2020)

Identification of MAGE-3 Epitopes Presented by HLA-DR Molecules to CD4(+) T Lymphocytes
por: Chaux, Pascal, et al.
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_k8bl8tgi6gu0m5qjuair00lr8n